Effect of NCB-02, Atorvastatin and Placebo on Endothelial Function, Oxidative Stress and Inflammatory Markers in Patients with Type 2 Diabetes Mellitus: A Randomized, Parallel-Group, Placebo-Controlled, 8-Week Study

Drugs in R and D

Volumn 9, Issue 4, 2008, Pages 243-250

  Usharani, P ^a   Mateen, A A ^a   Naidu, M U R ^a   Raju, Y S N ^a   Chandra, N ^a  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Atorvastatin, pharmacodynamics; Curcumin, pharmacodynamics; Endothelial function; Research and development; Type 2 diabetes mellitus

Indexed keywords

ATORVASTATIN; BIOLOGICAL MARKER; CHOLESTEROL; CURCUMIN; ENDOTHELIN 1; GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; METFORMIN; NCB 02; PLACEBO; SALBUTAMOL; SULFONYLUREA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CURCUMA LONGA; DEMOGRAPHY; DIARRHEA; DRUG EFFECT; DRUG SAFETY; ENDOTHELIAL DYSFUNCTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INFLAMMATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHOLESTEROL; CURCUMIN; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; PYRROLES; TRIGLYCERIDES;

EID: 46349109182     PISSN: 11745886     EISSN: None     Source Type: Journal    
DOI: 10.2165/00126839-200809040-00004     Document Type: Article

References (30)

1. Nishikawa T, Edelstein D, Du XL, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyper-glycaemic damage. Nature 2000 Apr 13; 404 (6779): 787-90
2. Neri S, Signorelli SS, Torrisi B, et al. Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls. Clin Ther 2005 Nov; 27 (11): 1764-73
3. Dogra G, Rich L, Stanton K, et al. Endothelium-dependent and independent vasodilation studies at normoglycaemia in type I diabetes mellitus with and without microalbuminuria. Diabetologia 2001 May; 44 (5): 593-601
4. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-20
5. Esposito K, Nappo F, Giugliano F, et al. Effect of dietary antioxidants on postprandial endothelial dysfunction induced by a high-fat meal in healthy subjects. Am J Clin Nutr 2003 Jan; 77 (1): 139-43
6. Cuevas AM, Germain AM. Diet and endothelial function. Biol Res 2004; 37 (2): 225-30
7. Vlachopoulos C, Aznaouridis K, Alexopoulos N, et al. Effect of dark chocolate on arterial function in healthy individuals. Am J Hypertens 2005 Jun; 18 (6): 785-91
8. Duffy SJ, Keaney Jr JF, Holbrook M, et al. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 2001 Jul 10; 104 (2): 151-6
9. Ramaswami G, Chai H, Yao Q, et al. Curcumin blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries. J Vasc Surg 2004 Dec; 40 (6): 1216-22
10. Balasubramanyam M, Koteswari AA, Kumar RS, et al. Curcumin-induced inhibition of cellular reactive oxygen species generation: novel therapeutic implications. J Biosci 2003 Dec; 28 (6): 715-21
11. Tousoulis D, Antoniades C, Vassiliadou C, et al. Effects of combined administration of low dose atorvastatin and vitamin E on inflammatory markers and endothelial function in patients with heart failure. Eur J Heart Fail 2005 Dec; 7 (7): 1126-32
12. Mozaffarian D, Minami E, Letterer RA, et al. The effects of atorvastatin (10 mg) on systemic inflammation in heart failure. Am J Cardiol 2005 Dec 15; 96 (12): 1699-704
13. Mohan IK, Kumar KV, Naidu MUR, et al. Protective effect of Cardipro against doxorubicin induced cardiotoxicity in mice. Phytomedicine 2006; 13: 222-9
14. Chowienczyk PJ, Kelly RP, MacCallum H, et al. Photoplethysmographic assessment of pulse wave reflection: blunted response to endothelium-dependent beta2-adrenergic vasodilation in type II diabetes mellitus. J Am Coll Cardiol 1999 Dec; 34 (7): 2007-14
15. Naidu MUR, Yashmaina S, Usharani P, et al. Comparison of two β2 adrenoceptor agonists by different routes of administration to assess human endothelial function. Indian J Pharmacol 2007; 39 (3): 168-9
16. Millasseau S, Kelly R, Ritter J, et al. Determination of age related increases in large artery stiffness by digital pulse contour analysis. Clin Sci (Lond) 2002; 103: 371-7
17. Tantikosoom W, Thinkhamrop B, Kiatchusakul S, et al. Randomized trial of atorvastatin in improving endothelial function in diabetics without prior coronary disease and having average cholesterol level. J Med Assoc Thai 2005 Mar; 88 (3): 399-406
18. Schalkwijk CG, Stehouwer CDA. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond) 2005: 109: 143-59
19. Economides PA, Caselli A, Tiani E, et al. The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes. J Clin Endocrinol Metab 2004 Feb; 89 (2): 740-7
20. Ceriello A, Assaloni R, Da Ros R, et al. Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients. Circulation 2005 May 17; 111 (19): 2518-24
21. Lam HC, Chu CH, Wei MC, et al. The effects of different doses of atorvastatin on plasma endothelin-1 levels in type 2 diabetic patients with dyslipidemia. Exp Biol Med (Maywood) 2006 Jun; 231 (6): 1010-5
22. Save V, Patil N, Moulik N, et al. Effect of atorvastatin on type 2 diabetic dyslipidemia. J Cardiovasc Pharmacol Ther 2006 Dec; 11 (4): 262-70
23. Mason RP, Walter MF, Jacob RF. Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress. Circulation 2004 Jun 1; 109 (21 Suppl. 1): II34-41
24. Ceriello A. New insights on oxidative stress and diabetic complications may lead to a 'causal' antioxidant therapy. Diabetes Care 2003 May; 26 (5): 1589-96
25. Joe B, Lokesh BR. Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochim Biophys Acta 1994 Nov 10; 1224 (2): 255-63
26. Sreejayan N, Rao MN. Free radical scavenging activity of curcuminoids. Arzneimittelforschung 1996 Feb; 46 (2): 169-71
27. Durgaprasad S, Pai CG, Vasanthkumar, et al. A pilot study of the antioxidant effect of curcumin in tropical pancreatitis. Indian J Med Res 2005 Oct; 122 (4): 315-8
28. Soni KB, Kuttan R. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol 1992 Oct; 36 (4): 273-5
29. Baum L, Cheung SK, Mok VC, et al. Curcumin effects on blood lipid profile in a 6-month human study. Pharmacol Res 2007 Dec; 56 (6): 509-14
30. Brennan P, O'Neill LA. Inhibition of nuclear factor kappaB by direct modification in whole cells: mechanism of action of nordihydroguairartic acid, curcumin and thiol modifiers. Biochem Pharmacol 1998; 55 (7): 965-73